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INTRODUCTION
Thymidine phosphorylase (TP) is an intracellular catalytic
enzyme involved in the reversible conversion of thymidine
to thymine. In addition, it has been reported that TP is com-
pletely identical to platelet-derived endothelial cell growth
factor (PD-ECGF) and has angiogenic activity (1).
Compared with adjacent non-neoplastic tissue, higher lev-
els of TP expression has been found in various cancer tissues
(2). In the cancer tissue, high TP expression by enzyme-link-
ed immunosorbent assay (ELISA) or positive TP expression
on immunohistochemical staining have been found to be
correlated with increased intratumoral microvessel density
(IMVD) (3-5). Moreover, patients with high or positive TP
expression in stomach cancer have shown a significantly worse
outcome than patients with low or negative TP expression
(6-11). For this reason, some investigators regard high or
positive TP expression in stomach cancer as independent poor
prognostic factors. 
However, most of these studies have focused on TP expres-
sion in cancer cells alone or evaluated TP expression in can-
cer tissue without discriminating whether the TP comes from
the cancer cells or cancer-infiltrating inflammatory cells
(CIICs) (4, 6-11). Recently, It has been reported that much
higher TP expression are observed in infiltrating-inflamma-
tory cells in the interstitium around cancer cells rather than
cancer cells themselves (7, 12-14). Although it has been re-
ported that high TP expression in stomach cancer are observed
in both CIICs and cancer cells themselves, little is known
which TP plays more significant roles as a prognostic factor
in the cancer tissue: TP in the cancer cells or in CIICs. In
brain cancer, it was reported that CIICs, even though cancer
cells themselves showed minimal TP expression, showed
high expression of TP, and the high TP expression of CIICs
was correlated with increased IMVD and poor prognosis (15).
We hypothesized the TP expression in CIICs has a strong
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The Expression of Thymidine Phosphorylase in Cancer-infiltrating
Inflammatory Cells in Stomach Cancer 
Thymidine phosphorylase (TP) has shown to be up-regulated in several cancers
and to play a role in angiogenesis and invasion. Most studies regarding TP have
focused on cancer cells. Recently, evidences suggest that TP in cancer-infiltrating
inflammatory cells (CIICs) also affect the cancer cell behavior. To evaluate the sig-
nificance of TP expression of CIICs in gastric cancer, we assessed TP expression
of cancer cells and CIICs separately using immunohistochemical assay on 116
paraffin-embedded tissue samples from stomach cancer patients and investigated
their clinical significance. When subjects were divided into 4 groups according to
the TP expression: cancer/matrix (+/+), C/M (+/-), C/M (-/+), and C/M (-/-), intra-
tumoral microvessel density scores were higher in the C/M (+/-) group than in the
C/M (-/-) group (p=0.02). For lymph node metastasis and survival, there were no
significant differences among the 4 groups. However, there were significant differ-
ences in survival (p=0.035) and LN metastasis (p=0.023) between the two groups
divided by TP expression of CIICs alone irrespective of TP expression of cancer
cells. Taken together, this study suggested the TP expression in CIICs could affect
lymph node metastasis and patients’ survival in gastric cancer.
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impact on the biology of the stomach cancer and the patients’
prognosis. To test this hypothesis, we separately examined
TP expression in cancer cells and CIICs in stomach cancer to
evaluate the significance of TP expression in CIICs in con-
junction with various clinical parameters such as histologi-
cal type, the depth of tumor invasion, lymph node metasta-
sis, IMVD, and the patients’ survival.
MATERIALS AND METHODS
Patients and tumor specimens
Paraffin-embedded tumor specimens were examined from
116 consecutively selected stomach cancer patients who had
undergone surgery at the Gyeong-Sang National University
Hospital from June 1998 to March 2002. The pathology
reports and medical records were carefully reviewed to con-
firm the correct disease status. The age of patients (87 males
and 29 females) ranged from 22 to 79 yr (median, 60 yr).
The patients were followed up for 1 to 53 months (median,
27 months), and the follow-up period was regarded as the
period after the surgery. After the initial review of all avail-
able hematoxilin and eosin (H&E)-stained slides of surgical
specimens, we selected a representative paraffin block from
each case for further study. The subjects were divided into
four groups on the basis of the separate assessment of TP
reactivity in cancer cells (cancer: C) and CIICs (matrix: M):
cancer/matrix (+/+), C/M (+/-), C/M (-/+), and C/M (-/-).
Of the 116 stomach cancer tissue samples, the subgroup of
C/M (+/+), C/M (+/-), C/M (-/+), and C/M (-/-) were 38,
26, 39, and 13, respectively. We examined the correlation
between the above mentioned patterns of TP expression and
various parameters including IMVD, the depth of tumor
invasion, lymph node metastasis, and patients’ survival. 
Immunohistochmistry
Sections were deparaffinized with xylene and dehydrated
with 98% ethanol. The staining procedure was achieved by
an immunoperoxidase technique on 5  m-thick consecutive
sections. Primary antibodies raised against TP (clone IC6-
203, a generous gift from Nippon Roche research center,
Japan, 1:750 dilution) and factor VIII (Dako, CA, U.S.A.,
1:50 ) were used. For epitope retrieval, specimens were pre-
treated with microwaves and an extra trypsin treatment for
factor VIII stain before incubation with primary antibodies
(room temperature, 60 min) (15). The negative controls for
some cases were parallel sections treated with the same pro-
cess as above, but omitting the treatment of primary anti-
bodies. Positive staining was visualized with diaminobenzi-
dine , followed by a light hematoxylin counter staining.
Assessment of TP immunoreactivity
Both staining intensity and percentage of positive cells were
used to assess immunoreactivity of TP. The staining intensity
was rated as weak, moderate, and strong as compared with
the background stain or some negative controls. Tumors
were considered as positive when more than 5% of cancer
cells demonstrated moderate or strong staining intensity or
more than 50% of cancer cells demonstrated weak intensity
(16). The CIICs were considered as positive, when more than
50% of infiltrating mononuclear cells close to the cancer cells
were stained with stronger than moderate intensity (14).
Histopathologic examination
Histologic typing and grading of tumors were mainly per-
formed according to the criteria established by the Japanese
classification of gastric carcinoma (17).
Assessment of angiogenesis
For each case, IMVD was determined as the maximum
number of microvessels under the light microscope within
the ‘‘hot spot’’, which was defined as those areas containing
the greatest number of capillaries and small venules at the
invasive edge, based on the criteria of Weidner et al. (18). The
‘‘hot spot’’ was determined by scanning the tumor sections
at low power (×40 and ×100). Subsequently, the microves-
sels were counted under the field using microscopic lens of
×200 power (×20 objective and ×10 ocular; 0.739 mm2/
field) at the ‘‘hot spot’’. The evaluations were done by pathol-
ogists who were blinded to the patients’ clinical status.
Statistical analysis
Among the 4 groups, the differences in both IMVD and
the number of lymph nodes that contained metastatic tumor
cells were examined using the Student’s t-test. Any correla-
tion between 4 groups and following clinical parameters such
as N-stage, T-stage, histological type, age, and sex were as-
sessed by chi-square test. The survival curve was calculated
by the Kaplan-Meier method and then analyzed with the
log-rank test. Statistical significance was defined as p<0.05.
RESULTS
TP expression and clinicopathological features
TP expression was identified as being heterogeneous in
the nucleus and/or the cytoplasm of cancer cells (Fig. 1). In
most positive cases, the TP reactivity in CIICs was stronger
than in cancer cells. Among the 4 subgroups, the cancer/ma-
trix (+/+) pattern was the most frequent one in differenti-
J.S. Jang, W.S. Lee, J.-S. Lee, et al.ated cancer, whereas cancer/matrix (-/+) was the most preva-
lent in the undifferentiated cancer (Table 1). Among the 4
subgroups, we could not find any significant difference in other
clinical parameters such as age, sex, T-stage, and N-stage. 
The relationships between TP expression pattern and
IMVD
As shown in Fig. 2, the statistical differences in IMVD were
observed among the 4 groups (p=0.02). Median IMVD score
according to the TP staining pattern were 47 (range, 22-123),
54 (range, 22-123), 45.5 (range, 7-112), and 37 (range, 22-
123) in the cancer (+)/matrix (+) group, cancer (+)/matrix
(-), cancer (-)/matrix (+), cancer (-)/matrix (-), respectively.
A statistically significant difference was found between cancer
(+)/matrix (-) or cancer (+)/matrix (+) and cancer (-)/matrix
(-) (p=0.02). This result suggests that TP expression in the
cancer cells may affect on intratumoral microvessel formation.
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Fig. 1. Immunohistochemical staining for thymidine phosphorylase (TP) in a gastric cancer specimen using antibody against TP. TP expres-
sion was heterogeneously identified in nucleus and/or cytoplasm of cancer cells and cancer-infiltrating inflammatory cells. (A) Positive stain-
ing is observed in the cytoplasm and nucleus of cancer cells and CIICs, Cancer (+)/Matrix (+). (×200). (B) TP-reactivity is observed in
the cytoplasm and nucleus of cancer cells and in less than 50% of CIICs, Cancer (+))/Matrix (-). (×200). (C) Note that most TP-positive
cells were CIICs, Cancer (-)/CIICs (+). (×200). (D) TP-reactivity is observed in less than 50% of CIICs and less than 5% Cancer cells Can-
cer (-)/Matrix (-). (×400). 
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The relationships between TP expression pattern and
both lymph node metastasis or survival
There was no significant difference in the number of lymph
node metastasis among the 4 groups. However, as shown in
Fig. 3, the group with matrix (+), when we divided the sub-
jects into two groups according to the TP reactivity of the
CIICs irrespective of the TP reactivity of the cancer cells,
showed to have a significantly larger number of metastatic
lymph node than that with matrix (-) (p=0.019).
For the relationship between the TP expression pattern and
patient’s survival, the Kaplan-Meier analysis showed a trend
of differences among the four groups (Fig. 4), but these differ-
ences, when assessed by a log-rank test, did not reach a sig-
nificant value (p=0.089). However, there was a statistically
significant difference in survival (p=0.02) when we assessed
the matrix (+) or matrix (-) group with survival for the same
relationship.
DISCUSSION
In this study, we found that high TP expression in CIICs
in stomach cancer was correlated with advanced lymph node
metastasis and poor prognosis. These findings are consistent
with the evidence that infiltrating inflammatory cells adja-
cent cancer cells may affect tumor cell biology. Previous stud-
ies on TP expression demonstrated TP expression in cancer
tissue is related to angiogenesis and poor prognosis, and they
focused on the cancer cells themselves or evaluated TP exp-
ression without discriminating as to whether it came from
cancer cells or CIICs (4, 6-11). One previous study demon-
strated that much stronger TP expression was observed in
C (+)
M (+)*
C (+)
M (-)
C (-)
M (+)
C (-)
M (-)
p
value
N
Age 
60 or less 63 17 11 27 8 NS
Older than 60 53 21 15 12 5
Sex
Male 88 31 21 28 8 NS
Female 28 7 5 11 5
T-stage
T1 30 9 7 9 5
T2a 14 5 6 2 1
T2-b 30 13 5 9 3
T3 42 11 8 19 4
N-stage
N0 50 16 10 18 6 NS
N1 38 13 12 9 4
N2 14 4 1 6 3
N3 14 5 3 6 0
Histology
Differentiated 48 23 9 12 4
Undifferentiated 66 14 16 27 9 0.026
Unclassified 2 1 1 0 0
Table 1. Clinicopathological features according to thymidine
phosphorylase expression
C, cancer; M, matrix.
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Fig. 2. Relationship between IMVD and TP expression. The sta-
tistical difference was found between cancer (-)/matrix (+) and
cancer (-)/matrix (-) (p=0.02).
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Fig. 3. Relationship between lymph node metastasis and TP expression. (A) No statistical difference in lymph node metastasis was shown
among 4 groups according to TP expression. (B) The patients with positive TP expression in CIICs showed more lymph node metastasis
in two groups divided by TP reactivity in CIIC (p=0.019). CIICs than cancer cells in the stomach cancer and suggested
that their TP expression should be related to angiogenesis
and prognosis (9). However, it did not determine which TP
is more important in angiogenesis or poor prognosis. The
current study has demonstrated that high TP expression in
CIICs in stomach cancer played more important roles in lym-
ph node metastasis and patients’ survival. The other merit
of this study is that the separate assessment of TP expression
leads to more accurate prediction of patients’ prognosis and
precise interpretation of other previous published results
regarding TP expression in the stomach cancer. For exam-
ple, two contradicting reports on TP expression are available,
which showed a relationship between the histological type
and TP expression in cancer tissue: one demonstrated that
differentiated stomach cancer had a higher TP positive rate
in tumor cell under immunohistochemical stain (9), where-
as the other report, when measured by ELISA, revealed that
the undifferentiated cancer type had higher TP levels in the
stomach cancer tissue (8). According to our results, we found
that the main source of TP in undifferentiated cancer tissue
was CIICs (Fig. 1) and its TP activity was superior to that of
cancer cells. Therefore, the contradicting results between the
two studies might be assumed to have come from the results
of the studies that measured TP from different main source:
the former TP from cancer cells and the latter TP mainly
from CIICs. Likewise, our separate interpretation can explain
the discrepancy of the two studies’ results. 
To assess the angiogenic activity, IMVD was measured;
the relationship between the 4 TP expression patterns and
IMVD was assessed in this study. The results demonstrated
that the C/M (+/±) group had a higher IMVD than the C
(-)/M (-) group, and this was consistent with previous studies
(5, 7, 10, 11). In addition, the C/M (±/+) group seems to
have higher IMVD than the group of C/M (-/-). Therefore,
we divided the subjects into two groups by TP expression of
cancer cells alone as well as CIICs alone to determine which
factor plays more important role in angiogenesis. However,
we could find no statistically significant differences between
any two groups (data not shown). These results suggested
that TP in CIICs might also play a cooperative role with TP
in cancer cells for microvessel formation.
For survival, we found certain tendency of different effects
among four groups, even though we did not clearly demon-
strated the survival difference in each of the 4 group (C/M
[+/+], C/M [+/-], C/M [-/+], and C/M [-/-]). This result
suggested that TP expression in cancer cells also affect pa-
tients’ prognosis, which is consistent with previous studies
(3, 4). However, we could not find a statistically significant
survival difference between two groups when we divided sub-
jects by TP expression of cancer cells alone (data not shown).
This finding suggests that the TP expression of cancer cells
alone cannot predict the patients’ prognosis. To prove the
difference among the 4 groups in terms of prognosis, a fur-
ther study on a much larger sample size seems to be needed.
Before this study, based on a series of reports that had demon-
strated that a high TP level in cancer tissue was related to
poor prognosis (3, 7, 8, 12, 14, 20), we expected that the
finding of TP expression of cancer cells in accordance with
increased IMVD and lymph node metastasis could affect on
the patients’ survival. In contrast, our study revealed that TP
expression in the CIICs have a stronger influence on lymph
node metastasis than that of cancer cells, and the impact of
TP expression of CIICs on microvessel formation may be
similar to that of cancer cells. The finding that the survival
was much influenced by TP expression in the CIICs in our
study is in agreement with the study that reported that the
TP-expressing macrophage in stomach cancer tissue may be
an independent prognostic factor (10).
In summary, we performed separate interpretation of TP
expression on cancer cells and CIICs to clarify the significance
of each cell type. We found that the TP expression in CIICs
may serve as an important variable that affects lymph node
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Fig. 4. The Kaplan-Meier curves for survival according to the TP expression patterns. (A) The patients were divided into 4 groups according
to TP expression. This graph shows a trend of survival differences among four groups, but these differences assessed by log-rank test did
not reach a statistically significant value (p=0.089). (B) A clear survival difference was observed when the patients were divided into two
groups as matrix-positive group and matrix-negative group regardless of TP reactivity of cancer cells (p=0.035).
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Bmetastasis as well as new vessel formation, and ultimately,
the survival of stomach cancer patients. These findings, may
lead a change in interpreting the TP expression in stomach
cancer tissue to predict the prognosis.
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